vimarsana.com
Home
Live Updates
Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury : comparemela.com
Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury
TORONTO, Feb. 27, 2024 -- Arch Biopartners Inc., , announced today that it had a pre-investigational new drug application meeting with the U.S. Food and Drug Administration Division of...
Related Keywords
Germany ,
Spain ,
Toronto ,
Ontario ,
Canada ,
United States ,
Italy ,
Australia ,
Canadian ,
Richard Muruve ,
Arch Biopartners Inc ,
Merck Sharp Dohme Research Laboratories ,
Venture Exchange ,
Drug Administration ,
Globenewswire Inc ,
Division Of Cardiovascular ,
Regulation Services Provider ,
Biopartners Inc ,
Renal Products ,
New Drug Application ,
Dohme Research Laboratories ,
Canadian Securities Administrator System ,
Electronic Document Analysis ,
Chief Science ,
Markets ,
comparemela.com © 2020. All Rights Reserved.